Luzitin

Luzitin, S.A. is a pharmaceutical company focused on the pursuit of innovative solutions for photodynamic therapy (PDT) and photodiagnosis.

Luzitin, S.A. is a pharmaceutical company focused on the pursuit of innovative solutions for photodynamic therapy (PDT) and photodiagnosis (PDD). Their mission is to investigate and develop innovative photosensitizing compounds to be used in Photodynamic Therapy (PDT) or Photodynamic Diagnosis (PDD) of cancer and other diseases, thus contributing to human wellness. They have reached proof-of-concept clinical trials (phase I/II) with their new therapeutic solutions and they are seeking a strategic alliance with third parties for further development. Luzitin offers access to a game changing and highly efficacious new molecular entity which will bring photodynamic therapy (PDT) into routine daily practice for the targeted therapy of solid tumors.